Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xintek is a medical technology company specializing in the development of carbon nanotube (CNT) based field emission X-ray sources. Founded as a spin-off from the University of North Carolina at Chapel Hill, the company pioneered the use of CNTs to create "cold cathode" X-ray tubes, which offer significant advantages over traditional thermionic filaments, including smaller size, faster switching, and the ability to create multi-beam arrays. This technology platform enables advanced medical imaging applications such as stationary digital breast tomosynthesis (s-DBT), which improves breast cancer screening by eliminating motion blur and reducing radiation dose. Xintek commercializes its innovations primarily through XinRay Systems, a joint venture with Siemens Healthineers, and continues to develop new applications in preclinical micro-CT and dental imaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xintek.